Display options
Cite
Ma L, Yi HJ, Yuan FQ, et al. An efficient strategy for establishing a model of sensorineural deafness in rats. Neural Regen Res. 2015;10(10):1683-9doi: 10.4103/1673-5374.153704.
Ma, L., Yi, H. J., Yuan, F. Q., Guo, W. W., & Yang, S. M. (2015). An efficient strategy for establishing a model of sensorineural deafness in rats. Neural regeneration research, 10(10), 1683-9. https://doi.org/10.4103/1673-5374.153704
Ma, Long, et al. "An efficient strategy for establishing a model of sensorineural deafness in rats." Neural regeneration research vol. 10,10 (2015): 1683-9. doi: https://doi.org/10.4103/1673-5374.153704
Ma L, Yi HJ, Yuan FQ, Guo WW, Yang SM. An efficient strategy for establishing a model of sensorineural deafness in rats. Neural Regen Res. 2015 Oct;10(10):1683-9. doi: 10.4103/1673-5374.153704. PMID: 26692870; PMCID: PMC4660766.
Copy Download .nbib Format: NLM
Share it on

Neural Regen Res. 2015 Oct;10(10):1683-9. doi: 10.4103/1673-5374.153704.

An efficient strategy for establishing a model of sensorineural deafness in rats.

Neural regeneration research

Long Ma, Hai-Jin Yi, Fen-Qian Yuan, Wei-Wei Guo, Shi-Ming Yang

Affiliations

  1. The Second Artillery General Hospital of Chinese PLA, Beijing, China.
  2. Department of Otolaryngology-Head & Neck Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  3. Department of Head and Neck Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, China.
  4. Department of Otolaryngology, Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.

PMID: 26692870 PMCID: PMC4660766 DOI: 10.4103/1673-5374.153704

Abstract

Ototoxic drugs can be used to produce a loss of cochlear hair cells to create animal models of deafness. However, to the best of our knowledge, there is no report on the establishment of a rat deafness model through the combined application of aminoglycosides and loop diuretics. The aim of this study was to use single or combined administration of furosemide and kanamycin sulfate to establish rat models of deafness. The rats received intravenous injections of different doses of furosemide and/or intramuscular injections of kanamycin sulfate. The auditory brainstem response was measured to determine the hearing threshold after drug application. Immunocytochemistry and confocal microscopy were performed to evaluate inner ear morphology. In the group receiving combined administration of furosemide and kanamycin, the auditory brainstem response threshold showed significant elevation 3 days after administration, higher than that produced by furosemide or kanamycin alone. The hair cells showed varying degrees of injury, from the apical turn to the basal turn of the cochlea and from the outer hair cells to the inner hair cells. The spiral ganglion cells maintained a normal morphology during the first week after the hair cells completely disappeared, and then gradually degenerated. After 2 months, the majority of spiral ganglion cells disappeared, but a few remained. These findings demonstrate that the combined administration of furosemide and kanamycin has a synergistic ototoxic effect, and that these drugs can produce hair cell loss and hearing loss in rats. These findings suggest that even in patients with severe deafness, electronic cochlear implants may partially restore hearing.

Keywords: furosemide; hair cell; kanamycin; nerve regeneration; neural regeneration; ototoxic drug; sensorineural deafness; spiral ganglion cells

References

  1. Lab Anim. 2010 Apr;44(2):124-31 - PubMed
  2. Otol Neurotol. 2007 Feb;28(2):223-31 - PubMed
  3. Brain Res Brain Res Rev. 1995 Jan;20(1):68-90 - PubMed
  4. Dev Neurobiol. 2009 Feb 1-15;69(2-3):153-61 - PubMed
  5. Hear Res. 1992 Apr;59(1):75-84 - PubMed
  6. Hear Res. 1993 Nov;70(2):205-15 - PubMed
  7. Hear Res. 2007 Apr;226(1-2):129-39 - PubMed
  8. Hear Res. 2011 Jul;277(1-2):4-19 - PubMed
  9. Acta Otolaryngol. 1979;88(5-6):369-81 - PubMed
  10. Hear Res. 2004 Jan;187(1-2):131-3 - PubMed
  11. Dev Dyn. 2009 Aug;238(8):1897-908 - PubMed
  12. Nature. 2002 Sep 19;419(6904):300-4 - PubMed
  13. Hear Res. 2010 Jan;259(1-2):16-23 - PubMed
  14. Biotech Histochem. 2009 Aug;84(4):159-77 - PubMed
  15. Acta Otolaryngol. 2009 Dec;129(12):1359-67 - PubMed
  16. J Assoc Res Otolaryngol. 2005 Jun;6(2):136-47 - PubMed
  17. PLoS One. 2012;7(9):e46355 - PubMed
  18. Audiol Med. 2009 Dec 1;7(4):189-199 - PubMed
  19. Tohoku J Exp Med. 1998 Oct;186(2):79-86 - PubMed
  20. Arch Otolaryngol. 1973 Jul;98(1):32-7 - PubMed
  21. Am J Otol. 1986 Jan;7(1):19-24 - PubMed
  22. Arch Otolaryngol. 1979 May;105(5):240-6 - PubMed
  23. Acta Otolaryngol Suppl. 1988;447:28-35 - PubMed

Publication Types